I am a
Home I AM A Search Login

Papers of the Week

2020 Jul 30

Cochrane Database Syst Rev


Vigabatrin add-on therapy for drug-resistant focal epilepsy.


Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG
Cochrane Database Syst Rev. 2020 Jul 30; 7:CD007302.
PMID: 32730657.


This is an updated version of the original Cochrane Review published in 2008 and updated in 2013. Epilepsy is a common neurological condition which affects up to 1% of the population. Approximately 30% of people with epilepsy do not respond to treatment with currently available drugs. The majority of these people have focal epilepsy. Vigabatrin is an antiepileptic drug licensed for use in drug-resistant epilepsy.